Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03619044 |
|---|---|
| Brief Title: | The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. (REVER) |
| First Submitted : | August 1, 2018 |
| First Submitted that Met QC Criteria : | August 1, 2018 |
| First Posted : | August 7, 2018 |
| Last Update Submitted that Met QC Criteria : | December 2, 2019 |
| Last Update Posted : | December 4, 2019 |